Inventories consist of (in thousands):

 

		March 31, 201 9				June 30, 2018
Raw materials		$	37,176			$	30,956
Finished goods			56,663				54,692
Inventories, net		$	93,839			$	85,648

 

 

Property and equipment consist of (in thousands): 

 

		March 31,				June 30,
		201 9				2018
Land		$	7,065			$	7,065
Buildings and improvements			172,826				170,110
Machinery and equipment			117,105				107,625
Property and equipment, cost			296,996				284,800
Accumulated depreciation and amortization			(151,677	)			(139,452	)
Property and equipment, net		$	145,319			$	145,348

 

 

Intangible assets consist of (in thousands): 

 

		March 31,				June 30,
		201 9				2018
Developed technology		$	422,039			$	305,303
Trade names			147,340				89,608
Customer relationships			212,996				212,228
Patents			1,981				1,401
Intangible assets			784,356				608,540
Accumulated amortization			(205,214	)			(162,208	)
Intangible assets, net		$	579,142			$	446,332

 

Changes to the carrying amount of net intangible assets for the months ended consist of (in thousands):

 

Beginning balance		$	446,332
Acquisitions			177,500
Other additions			558
Amortization expense			(43,797	)
Currency translation			(1,451	)
Ending balance		$	579,142

 

The estimated future amortization expense for intangible assets as of is as follows (in thousands):

 

2019 (remainder)		$	14,868
2020			58,873
2021			58,518
2022			56,822
2023			54,942
Thereafter			335,119
Total		$	579,142

 

 

Changes to the carrying amount of goodwill for the months ended consist of (in thousands):

 

		Protein Sciences				Diagnostics and Genomics				Total
Beginning balance		$	347,918			$	249,972			$	597,890
Acquisitions (Note 4)			13,582				110,066				123,648
Currency translation			(1,821	)			(108	)			(1,930	)
Ending balance		$	359,679			$	359,929			$	719,608

 

We evaluate the carrying value of goodwill in the quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a quantitative assessment for all of its reporting units during the quarter of fiscal The quantitative assessment indicated that all of the reporting units had substantial headroom as of

 

During the quarter ended the Company realigned the management of certain business processes between reporting units within the same reportable segment. A goodwill allocation was performed between the impacted reporting units based on the relative fair value of the processes realigned. In conjunction with the realignment, a quantitative goodwill impairment assessment was performed both prior to and subsequent to the realignment. The quantitative assessment indicated that all of the impacted reporting units had substantial headroom both prior to and subsequent to the realignment.   triggering events or items beyond the realignment that would require a goodwill impairment assessment were identified during the months ended There has been impairment of goodwill since the adoption of Financial Accounting Standards Board (“FASB”) ASC guidance for goodwill and other intangibles on